A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
Clinical trial NCT06105255 · COMPLETED
Trial details
- NCT number
- NCT06105255
- Sponsor
- InventisBio Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2024-02-02
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.